SCHEMBL6792530

SCHEMBL6792530

Nc1cccc(C=CC(=O)c2ccc(NC(=O)c3ccccc3-c3ccc(C(F)(F)F)cc3)cc2)n1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 3/20 0.47
TRPV1 Q8NER1 3/20 0.45
APOB P04114 5/20 0.45
ALDH1A1 P00352 1/20 0.45
POLB P06746 1/20 0.45
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
MEN1 O00255 1/20 0.45
P4HB P07237 1/20 0.45
KMT2A Q03164 1/20 0.45
MTTP P55157 5/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
KIT P10721 1/20 0.42
LMNA P02545 1/20 0.42
CYP1A1 P04798 1/20 0.42
MAOB P27338 1/20 0.42
CYP1B1 Q16678 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6792525 1.00 PTGS1 (0.47) PTGS1TRPV1APOBALDH1A1POLB
SCHEMBL6793556 0.89 APOB (0.48) PTGS1TRPV1APOBALDH1A1POLB
SCHEMBL6793558 0.89 APOB (0.48) PTGS1TRPV1APOBALDH1A1POLB
SCHEMBL6788066 0.87 TRPV1 (0.59) PTGS1TRPV1APOBALDH1A1POLB
SCHEMBL6788063 0.87 TRPV1 (0.59) PTGS1TRPV1APOBALDH1A1POLB
SCHEMBL6793533 0.87 APOB (0.48) PTGS1TRPV1APOBALDH1A1POLB
SCHEMBL6793531 0.87 APOB (0.48) PTGS1TRPV1APOBALDH1A1POLB
SCHEMBL6798035 0.79 HPGD (0.55) TRPV1ALDH1A1POLBHPGDHTT
SCHEMBL6798031 0.79 HPGD (0.55) TRPV1ALDH1A1POLBHPGDHTT
SCHEMBL7087177 0.79 SORT1 (0.46) APOBPOLBMEN1KMT2AMTTP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors APOB, APOL1, SCARB1 PTGS1 1382/4885TRPV1 3714/4885APOB 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.